Abstract
The treatment of bone infections has always been difficult. The emergence of drug-resistant bacteria has led to a steady decline in the effectiveness of antibiotics. It is also especially important to fight bacterial infections while repairing bone defects and cleaning up dead bacteria to prevent biofilm formation. The development of biomedical materials has provided us with a research direction to address this issue. We aimed to review the current literature, and have summarized multifunctional antimicrobial materials that have long-lasting antimicrobial capabilities that promote angiogenesis, bone production, or “killing and releasing.” This review provides a comprehensive summary of the use of biomedical materials in the treatment of bone infections and a reference thereof, as well as encouragement to perform further research in this field.
1 Introduction
Bone infection, usually referring to that caused by bacterial infection in which bone lesions completely destroy the bone, is not common but it is a catastrophic condition (). According to statistics, when comparing the periods of 1969–1979 and 2000–2009, the incidence of orthopedic infections in the United States increased from 11.4 to 24.4 times per year per 100,000 residents, respectively (). In Spain, when comparing 1985–1991 to 2007–2011, the incidence of orthopedic infections increased from 2.34 to 5.78 per year per 100,000 inhabitants, respectively (). The overall prevalence of orthopedic infections in Germany increased from 15.5 to 16.7 cases per year per 100,000 inhabitants from 2008 to 2018 (), and that in South Korea increased from 7.8 to 9.1 in 2008–2016 (). It is expected that, in the near future, the number of orthopedic implant-related infections will further increase ().
Orthopedic implant-related infection is one of the major early postoperative complications in artificial joint surgery, usually occurring within 3 months after surgery. Osteomyelitis (OM) and prosthetic joint infection (PJI) are serious deep tissue infections. There are various sources of infection such as bacteremia, spread or injury from nearby tissues, and after surgery or foreign body implantation (; ). Implant infection is most commonly caused by bacteria of coagulase negative Staphylococcus. Staphylococcus aureus (S. aureus) is often thought of as the main pathogen ().
The treatment of PJI has traditionally used a 2-stage revision. Phase 1 revisions are now increasingly used (). However, patients may require long-term antibiotic therapy and repeated revision surgery leads to dysfunction and even amputation. In addition to revision joint replacement surgery and other implant-related infections, such as open fractures, the surgical site of primary joint arthroplasty infection is more common and a difficult disease to cure clinically (). Although systemic antibiotics are currently one of the most important and effective methods to treat bone infections, their use can lead to bacterial biofilm and bacterial resistance. For example, vancomycin is the gold standard in the treatment of methicillin-resistant S. aureus (MRSA) infection, but the minimum inhibitory concentration (MIC) of vancomycin in the treatment of MRSA is on the rise (; ; ).
Although traditional surgical treatment of bone infection quickly relieves symptoms, it may cause patients to become prone to repeated infections and severe surgical trauma. There is an urgent need to develop new treatment modalities to achieve better therapeutic effects. At present, the use of antibacterial materials for the treatment of bone infection has become a hot research topic. To reduce the morbidity of implant-related bacterial infections, biological medicine and the use of antibacterial materials is being given more attention ().
Common antibacterial materials can be divided into organic, inorganic and a combination of any two of these materials. Organic material, such as polymethyl methacrylate (PMMA) bone cement mixed with antibiotics, has been widely used clinically in the past (; ; ; ). However, the polymerization temperature of PMMA is very high, which restrict the use of antibiotics (). Therefore, more reliable antibacterial activity materials were developed. Inorganic materials (e.g., calcium sulfate, hydroxyapatite), which have received much attention in recent years, have begun to be widely used clinically (; ; ). Due to the biodegradable properties of these materials, they are gradually degraded within the body without secondary surgery, reducing repeated operations caused by trauma and other stimuli. Additionally, this reduces the amount of antibiotics used, which is accompanied by prolonged release, so that local antibiotics can be more effective. However, antimicrobial materials have limited applications, and often lack the functions we need, such as promoting osteogenesis, angiogenesis. As research and development of antibacterial materials has advanced, multifunctional implant antibacterial materials have become a trend. These materials combine biological compatibility and coagulation function, promote osteoblast proliferation, and possess multiple advantages of resistance to infection ().
Although the combination of biomedical materials and antibiotics has been a huge success, implant-related infections continue to add pressure to the global healthcare system (). Due to the complex mechanism of bacterial infection and the barriers to delivery of antibiotics to the site of infection, the choice of antibiotic delivery methods has also attracted attention. Microstructural surface morphology changes in antimicrobial materials also enhance the functionality of the material (; ; ). Antibiotic delivery methods commonly used today are coatings, nanoparticles, three-dimensional (3D) scaffolds, and hydrogels (; ; ; ). The choice of appropriate antibiotic delivery enables us to deal with different kinds of bacterial infection in a more efficient manner.
We aimed to investigate the current research status of antibacterial materials, which are divided into organic materials, inorganic materials, and composite materials according to their chemical structures. We then propose that, with the current complexity of bone infection and the development of antibacterial materials, the introduction of multifunctional implantable antibacterial materials helps to overcome the difficulty in treating infections. Among these antibacterial materials, there are those that exhibit bactericidal or bacteriostatic activity by releasing antibiotics, those that repel bacterial adhesion, and those that combine multiple functions other than antibacterial properties, such as blood coagulation and promotion of osteoblast proliferation (Scheme 1). This review focuses on the characteristics of antibacterial materials in the treatment of orthopedic infections, the ability of antibacterial materials to load antibiotics, and the effect of drug sustained release on the prevention and treatment of orthopedic infections. We also focus on the application of antimicrobial materials for orthopedic-related infections to evaluate novel antimicrobial materials. Our analysis is intended to serve as a guide for researchers in the selection of appropriate antimicrobial materials for different conditions of orthopedic infection and to evaluate novel antimicrobial materials.
SCHEME 1
2 Application of antibacterial materials
Widely studied antimicrobial materials are divided into organic antimicrobial materials, inorganic antimicrobial materials, and organic-inorganic composites.
2.1 Organic materials
Organic materials contain synthetic organic polymer materials and natural organic materials. Among them, synthetic organic polymer materials include polymethyl methacrylate and polyglycolic acid, and natural organic materials include chitosan, alginate, and hyaluronic acid. They do not have antimicrobial properties per se, but function as carriers of drugs or antimicrobial materials.
2.1.1 Synthetic organic polymer materials
2.1.1.1 PMMA
PMMA-combined antibiotics have been used in the treatment of infected bone defects for many years in bone defects bearing a higher capacity after implantation. PMMA itself is not antibacterial, but it can be loaded with antibiotics, with the advantage of high concentrations of local antibiotics. However, polymerization temperatures are very high, and require that PMMA antibiotics have thermal stability (). For this reason, gentamicin and tobramycin are often mixed into PMMA bone cement (); non-etheless, the heat released during the polymerization of PMMA still leads to the explosive release of antibiotics, resulting in a less-than-expected duration of effective antibiotic concentration. Therefore, to improve the efficiency of PMMA releasing antibiotics, the selection of different kinds of antibiotics and different preparation methods have become the focus of current research. Gentamicin-loaded silica nanoparticles are used to prolong gentamicin release for several weeks, and the gentamicin released from the antibiotic bone cement mixture has the same concentration as exhibited after 1 day. However, the subsequent release of antibiotics was less pronounced, with less gentamicin released after approximately 27 days ().
made different antibiotic loaded bone cements (ALBCs) containing vancomycin, teicoplanin, ceftazidime, imipenem, piperacillin, gentamicin, and tobramycin, respectively, and studied the antibacterial effects. According to their high-performance liquid chromatography results, all test samples on the first day showed a burst release. Then, in the next few days, the release rate dropped rapidly. The different ALBCs showed different release durations and additional daily release rates. Those containing gentamicin were more likely to have a longer release duration (10 days) than ALBCs containing ceftazidime (6 days), tobramycin (5 days), vancomycin, teicoplanin, imipenem, and piperacillin (all 2 days). The antibiotic concentrations of bone cement are also affected by the compressive ability, and the cellular compatibility with clindamycin (CLI) loaded PMMA cement had high compressive strength (∼120 MPa). Compared with the high loading of CLI cement, low loading CLI PMMA cement has better cell compatibility, because the CLI release rate is low, and cell adhesion on the surface of the cement is better ().
As an orthopedic implant material with a long history of use, PMMA bone cement has excellent shape plasticity and mechanical properties. However, when it polymerizes, it releases a large amount of heat, which may easily cause tissue damage and shorten drug release times. Furthermore, it is a biologically inert material, which has poor bonding with bone tissue and is prone to detachment. The solutions to these problems depend on the combined efforts of further studies.
2.1.1.2 Poly lactic-co-glycolic-acid
Poly lactic-co-glycolic-acid (PLGA), a polylactic acid (PLA) and polyglycolic acid (PGA) copolymer, has undergone extensive research. PLGA is not antimicrobial, but it is widely used as a carrier in the treatment of bone infections. Due to its biocompatibility and biodegradability, PLGA degrades quicker, has adjustable mechanical performance (), has been shown to be an excellent delivery vehicle for antibiotics for the treatment of bone infections (; ). In general, PLGA degradation and drug release rates are accelerated by greater hydrophilicity, increased chemical interactions between hydrolyzed groups, less crystallinity, and greater volume-to-surface ratio (). used a combination of vancomycin-loaded and daptomycin-loaded PLGA microspheres; the formulations retained their surrounding bone structure to a greater extent and cement modified with daptomycin-loaded PLGA microspheres may significantly preserve tissue structure from S. aureus infection.
used PLGA mixed with vancomycin and hot compress molding to form an antibiotic bead to treat bone infection. An 18F-FDG PET scan was used to monitor responses to treatment of bone infection. The results showed successful eradication of S. aureus pathogens from the bone using the biodegradable PLGA vancomycin beads, with better cytocompatibility and osteogenic properties, and inhibition of biofilm formation. This is a promising treatment material for infectious bone defects. Furthermore, studies by gamma ray show more connections of hydrophilic iodide molecules to PLGA surfaces by poly (lactic-co-glycolic acid)-graft-polyvinylpyrrolidone/polyiodide (PLGA-g-PVP/I) (), and the antibacterial effects were verified by rat models. Scanning electron microscopy was performed to examine the morphology of the bacteria after incubation with these PLGA-g-PVP/I membranes. The results showed that the cells maintained their normal shape after 1 h of contact with the blank PLGA membrane. In contrast, cells were more severely damaged when incubated with PLGA-g-PVP/I membranes. The authors used two different incubation methods to verify the antimicrobial mechanism, and the results showed that the PLGA-g-PVP/I membrane in direct contact with bacteria was significantly superior in its leaching solution. In vitro glutathione (GSH) oxidation analysis of S. aureus after incubation with PLGA-g-PVP/I membranes for a period revealed that its antimicrobial properties were related to reactive oxygen species (ROS) production.
In sum, PLGA has good biocompatibility, biological safety, and biodegradability that makes it a widely used and effective drug carrier material. Antibiotics load by PLGA microspheres have potential advantages for the treatment of osteomyelitis (). However, the degradation conditions of PLGA are relatively harsh and need to be studied extensively.
2.1.2 Natural organic polymer materials
Natural organic polymer materials have high biological activity, low toxicity, get easy degradability, rich in resources and advantages of by people more and more attention. These natural polymers can be used by self-assembly or crosslinking technology to form a natural polymer, thus forming the cytotoxicity of polymer, to form a stable water gel or stent with retained polymer properties ().
2.1.2.1 Chitosan
Chitosan has excellent biodegradability and good antibacterial activity, biocompatibility, non-toxicity, and physical and chemical properties (). As a result, chitosan has been widely used in the field of antibacterial treatment, such as forming antimicrobial coatings and antimicrobial scaffolds. Chitosan and its derivatives have antibacterial activity against fungi, Gram-positive bacteria, and Gram-negative bacteria, and are antibacterial materials that have attracted much attention in recent years. There are many reports showing that chitosan has excellent antibacterial activity.
For example, quaternate chitosan, hydroxypropyl trimethyl ammonium chloride chitosan (HACC), was grafted onto a 3D-printed scaffold composed of polypropeptide coglycolactone and hydroxyapatite to design bone tissue engineering scaffolds with antibacterial and osteoconductive properties PLGA/Hydroxyapatite/HACC(P/HA/H) (). The scaffolds grafted with HACC have good antibacterial properties and biocompatibility and, after implantation under the skin of mice (Figure 1A), the number of viable bacteria was significantly decreased in both groups of scaffolds grafted with HACC after 24 h of observation using confocal laser scanning microscopy technique. Moreover, human mesenchymal stem cells (hMSCs) were co-cultured on the surface of the HACC scaffold for 24 h, and the percentage of dead cells in the scaffold was significantly lower than in the control group (p < 0.05) (Figure 1B). Real-time monitoring of the bacterial photon intensity of Xen29 in the subcutaneous embedding model at days 0–14 revealed a low level of signal detected on the scaffold grafted with HACC (Figure 1C). After 14 days of scaffold inoculation, quantitative analysis of bacteria in various scaffolds by obtaining cultures in rat inoculated scaffolds revealed a significant reduction in HACC scaffold load (p < 0.01) (Figure 1D).
FIGURE 1
Studies also show that one step by electrophoretic deposition technique was used to prepare the antibiotics slow-release chitosan bioactive glass composite coating. In the use of vancomycin antibiotic drug loading and release of composite coating, the production of the uniform coating thickness is close to 55 µ, containing 23.7 wt% bioactive glass particles and various amount of antibiotics. Coating simulated body fluid of bioactive apatite formation showed good adhesion and cell growth (
Chitosan bioactive glass composite coating elution kinetics in vitro showed that, in the first elution steps at 1 h, approximately 40% of the drug underwent initial burst release, followed by elution for more than 4 weeks. This shows the potential of long-term drug delivery. In tests of Gram-positive S. aureus bacteria survival to determine the effect of vancomycin release to reduce the risk of infection, by suspending liquid containing ≥0.5 gd vancomycin on the preparation of the coating, almost no bacteria survived (
2.1.2.2 Alginate
Sodium alginate is a non-toxic, good biocompatibility, low cost natural polymer material. Alginate itself has no antibacterial properties. It is as drug carrier and tissue engineering repair material shown to have broad applications (
2.1.2.3 Hyaluronic acid
Hyaluronic acid is a linear sugar glycosaminoglycan, one of the major components of the extracellular matrix, due to its good biocompatibility, hydrophilicity, antigenicity, and lubricity, and is widely used in ophthalmology, trauma, arthroplasty, plastic surgery, and other fields. Hyaluronic acid as a carrier for antibacterial materials or drugs, and shows good application potential in the field of tissue engineering (
Although hyaluronic acid coatings increase cell membrane permeability, they also destroy the integrity of the bacteria, achieving an efficient antibacterial effect (
2.2 Inorganic materials
Inorganic materials include calcium sulfate (CS), hydroxyapatite, and metals. Among them, CS and hydroxyapatite have no antimicrobial properties per se and are mainly used as carriers of antimicrobial units and bone fillers in the treatment of bone infections. Metals mainly function in the form of nanoparticles.
2.2.1 Calcium sulfate
CS, as a slow-release antibiotic carrier, has been widely used clinically to cure diseases such as osteomyelitis and infected bone defects. Calcium sulfate is also an important bone filling material. The implanted CS antibiotic carrier support strength promotes the repair of bone tissue and the absorbability does not cause an apparent host response in the recipient area. This creates a calcium-rich environment, whereby the calcium ions may provide some stimulus to the osteoblasts and participate in the formation of new bone (
2.2.2 Hydroxyapatite
Hydroxyapatite (HA) is a new biological material; its structure is consistent with the inorganic components of bone and it occupies an important position in the treatment of bone infection, with good application prospects. Because it has good biocompatibility and bone conductibility, no cytotoxicity, no immunogenicity, and enough drug-polymer interactions, and because its degradation speed can be controlled, HA is considered to be an excellent release carrier of antibiotics and synthetic bone substitutes (
Many in vitro experiments have confirmed the therapeutic effect of HA (
2.2.3 Metal
Since ancient times, metal has been used as an antimicrobial agent applied in medical and other fields. Metal nanoparticles are made into antimicrobial coatings or antimicrobial scaffolds for the treatment of bone infections. Copper (Cu) and silver (Ag) containers were used to store food and disinfectant, and copper salt was used to prevent fungal disease (
Metals are mainly applied to orthopedic implants in the form of coating or alloying (
FIGURE 2

(A) Schematic diagram of the antimicrobial effect of the magnesium/zinc metal coating. (B) Quantitative statistics of implant surface bacterial inhibition on coated plate images, n = 8, **p < 0.01. (C) Antibacterial effect of S. aureus under different substrates, n = 6, *p < 0.05 and **p < 0.01. (D) Antibacterial effect of E. coli under different substrates, n = 6, *p < 0.05 and **p < 0.01. Copyright 2019, Elsevier Ltd. Reproduced with permission (
The antibacterial properties of nanometer metal particles show great potential. Nanometer metal particles sterilization mechanisms include cell membrane damage, protein functional inactivation, and oxidative stress. In addition, the use of metal reduces bacterial adhesion. For example, the calcium-deficient calcium titanate generated by the introduction of Sr and Ag ions onto titanium (Ti) by a three-step aqueous solution treatment combined with heat, Sr, and Ag ions exhibits excellent bone growth-promoting ability and antibacterial activity (
2.3 Composites
Due to their limitations, single organic or inorganic materials often do not reach the requirements of clinical applications, giving rise to composite materials. Composites are formed by two or more materials and make full use of their combined advantages, good biocompatibility, strength, and antibacterial properties. The structure of the material can also affect cell function, survival, and tissue formation (
TABLE 1
| Compose | Antibacterial activity | Implant | Bacteria | Advantage | References |
|---|---|---|---|---|---|
| Silver ion doped ceramic nano powder | Compared to the control group, bacterial adhesion was significantly reduced | Rabbit femur | MRSA | Good biocompatibility, long-lasting antibacterial effect | |
| Gentamicin sulfate loaded chitosan with aloe (CS/AV) integrated on Ti alloy | GS drug-loaded samples showed very clear areas of inhibition for both S. aureus and E. coli | Not tested in vivo | S. aureus (ATCC 25923) and E. coli (ATCC 25922) | Good hydrophobicity, biocompatibility, biodegradability, and bactericidal resistance | |
| Graphitic diyne (GDY) composite TiO2 nanofibers | Destroying existing biofilms prevents the formation of biofilms compared to the control group | Mouse femur | MRSA | Excellent bone induction performance, good biocompatibility | |
| D-amino acids (D-AAs) and engineered gold nanorods (AuNRs) | Significant biofilm destructive activity was exhibited compared to the control group | Not tested in vivo | MRSA | Cell membranes are destroyed by photothermal treatment and do not cause thermal damage to the surrounding soft tissues | |
| Nano hydroxyapatite/collagen/CS hemihydrate (nHAC/CSH) | In the VCM/nHAC/CSH dish of the agar matrix center, the inhibition ratio of VCM/nHAC/CSH was greater than 99.8% | New Zealand rabbit femur | MRSA | Self-defining, antibacterial, porous, degradable, good mechanical properties, good osteogenesis activity | |
| CMCS and CDM-loaded mesoporous silica nanoparticles (MCM-41) | There was complete bacteriostatic activity throughout the duration of the test | Not tested in vivo | Streptococcus blood (ATCC 10 556™) | Enhance drug loading capacity, and maintain drug release with a fading sudden release effect, stimulate osteogenesis | |
| Mesoporous silica nanoparticles and gelatin matrix | Compared with the control group, mesoporous silica nanoparticles and gelatin matrix composite scaffolds had a larger antibacterial inhibition zone | New Zealand rabbit radius | Gram-positive bacteria S. aureus | Improved bone regeneration in contaminated bone defects can be achieved | |
| Van/PLGA is loaded into β-tricalcium phosphate scaffold | Compared with the blank stent group, CPSF has a significant antibacterial effect, and the size of the inhibition zone gradually decreases over time | New Zealand rabbit tibia | S. aureus | Fills the bone defect, induces osteogenesis, accelerates the reconstruction of bone tissue | |
| pTi/CS/HAP-Se | The composite scaffold is gradually dissolved and degraded into low molecular weight fragments after CS perfusion to exert an antibacterial effect | In vivo testing was not performed | S. aureus and E. coli | Osteoblasts proliferate while inhibiting tumor cell growth | |
| Silk fibroins (SF) and AgNPs | Compared with pure SF stents, when the Ag concentrations were 0.1%, 0.5%, and 1%, the inhibition rate of stents increased from 51.8% to 51.8%, 72.3%, 77.5%, respectively | Rat tibia | MRSA | Promotes the growth and differentiation of various cells such as osteoblasts, bone marrow mesenchymal stem cells, and adipose stem cells, and stimulates angiogenesis | |
| Calcium sulfate/calcium biphasic phosphate composite PMMA | This makes the local tissue pH alkaline and may interfere with bacterial growth and osteoclast activity | Rabbit tibia, rat tibia | Coagulase-positive MRSA strain | Multi-barrier, drug-eluting is biodegradable | |
| VC and GC-loaded chitosan-montmorillonite nano-clay composites (CS/MMT) | The concentration of the drug released during all time intervals was higher than the MIC value | In vivo testing was not performed | S. aureus (RSKK 1009) and E. coli (ATCC 25922) | There is no cytotoxic effect on fibroblasts and human osteoblast-like cells | |
| Mesoporous silica SBA-16/HA-based | Ciprofloxacin-free SBA-16/HA and SBA-16APTES show significant antibacterial activity against E. coli | Swiss mice | S. aureus, Pseudomonas aeruginosa, E. coli, and Bacillus cereus | Good biocompatibility |
Summary of antibacterial composite materials for implant-related infections.
To improve the combination and advantages of a variety of materials, researchers and manufacturers use coatings, nanoparticles, hydrogels, and antibacterial bracket structures to achieve a better fit. For example, nanostructured composites in the form of coatings, which embed bioactive compounds in inorganic nanostructured matrixes, incorporate biopolymers and bioactive nanoceramics that mimic organic components of the bone extracellular matrix (such as collagen) to induce bone growth (
In one study, several sets of different ratios of methyl methacrylate (MMA), 3-(trimethoxy silyl)propyl methacrylate (KH570), borneol acrylate (BA), and hybrid silica sol were mixed in a solution to prepare organic-inorganic hybrid antimicrobial coatings (Figure 3A) (
FIGURE 3

(A) Conceptual diagram of the organic-inorganic hybrid antimicrobial coating. (B) Analysis of the adhesion of E. coln different coatings. **p < 0.01, ***p < 0.001. (C) Analysis of the adhesion of S. mutans to different coatings. **p < 0.01, ***p < 0.001. (D) OD test to detect E. coil growth inhibition. (E) OD test to detect S. mutans growth inhibition. Copyright 2019, American Chemical Society with permission (
Nanostructured Ag has excellent antibacterial activity, and one of the main mechanisms of bactericidal activity is cytotoxicity caused by ROS (
By adding a hydrogel matrix nanometer conductive filler, water can be manufactured into an injectable conductive gel. These hydrogels enhance antibacterial activity and reduce cytotoxicity by enhancing electrical signal transmission and simulated physiological environment within an organism (
3 Anti-infection and multifunctional materials
Frequent implant-related infections, leading to catastrophic results, make patients face a more complex physiological environment. With the development of composite materials, anti-infection material function has become more diversified. They have specific bioactive components as a way to provide specific functions (such as Biocompatible, promotes angiogenesis, osteogenesis, promotes coagulation and clears dead bacteria). Here, we discuss the different functional antimicrobial materials and their associated bioactive components separately. Some of the biomaterials with special functions are listed in Table 2.
TABLE 2
| Bioactive ingredients | Function | Basic antibacterial materials | Applications | RIS |
|---|---|---|---|---|
| Serine protein (SF) | Excellent mechanical properties, good biocompatibility and biodegradability | Gentamicin, AgNPs | Vancomycin-loaded SF-AgNPs scaffolds | |
| Zn2+ | Promotes angiogenesis and osteogenesis | Zeolite imidazole acid skeleton-8 (ZIF-8) | Preparation of ZIF-8 nano-organic skeleton by solvent method | |
| PLGA | Biodegradable, with good biocompatibility | AgNPs, Stainless steel alloy | Implants with PLGA/AgNPs coating | |
| Poly(3-hydroxybutyrate-co-3-hydroxypentanoate) (PHBV) | Excellent biocompatibility and biodegradability | CuO, AgNPs | PLA- and PHBV composites containing nanoparticles | |
| Genipin(GP) | Good compatibility and low cytotoxicity | Multifunctional carbon dots (CDs) | A novel nitrogen co-doped carbon dot-dye wood covalent conjugate (N-CDs-GP) was synthesized by hydrothermal method | |
| Vascular endothelial growth factor (VEGF) | Vascular endothelial cell migration, proliferation | Cu2+ | 3D printed hybrid scaffold with bionic hierarchical porous structure | |
| Cu2+ | Stimulates angiogenesis and collagen deposition | Cu2+ | Biocomposites containing copper Mesoporous bioactive glass | |
| Bioactive glass (BG), Ga | Stimulates expression of osteoblast genes and stimulates angiogenesis, Inhibit bone resorption and increase calcium deposition in bone tissue | Ga, Carboxymethyl cellulose (CMC), dextran | Ga-containing BG particles form hydrogel composites | |
| Mg2+ | Local Mg-rich environment improves osteoblast adhesion rate, promotes new bone production and regulates osteoblast signaling | Mg2+, TiO2 | Preparation of magnesium-doped titanium dioxide microporous coatings on the surface of Ti implants | |
| Graphdiyne (GDY) | Good osteogenic ability and promotes osteoblast adhesion | TiO2, GDY | Assembly of GDY onto TiO2 as a coating for titanium implants by changing the surface charge of GDY and TiO2 | |
| Mesoporous silica spheres | Absorbs water from wounds, promotes clotting factor activation, and is degradable | Ca2+, Ag2+ | Calcium-silver doped ordered mesoporous silica spheres for antibacterial and hemostatic applications | |
| Chitosan | Positively charged chitosan tends to adsorb negative proteins, which leads to platelet activation and thrombosis | Ag-NPs | Preparation of chitosan nanofibers by electrostatic spinning | |
| Carboxymethyl kappa-carrageenan | Interacts with blood proteins to promote clotting and absorbs exudate from wounds | Carboxymethyl kappa-carrageenan | Mixing Carboxymethyl kappa-carrageenan with poly(vinyl alcohol) to introduce antibacterial activity and procoagulant activity into nanofibers | |
| Poly(N-isopropylacrylamide) | Unique temperature responsiveness with improved wettability and adhesion properties | Lysozyme | Modulation of spatial hiding and exposure of adsorbed lysozyme by temperature-triggered hydration and conformational changes | |
| Poly(methacrylic acid) | Imparts pH responsive | Lysozyme | The poly(methacrylic acid) chain imparts pH-responsive properties to the system for stepwise modulation of surface and lysozyme/bacterial interactions | |
| Poly(carboxybetaine methacrylate) | An amphoteric polymer that strongly interacts with water to release of dead bacteria | Ag-NPs | Silver nanoparticles embedded in a polymer matrix capable of killing bacteria on contact and releasing dead bacteria under moist conditions |
Functions and applications of bioactive components in biomaterials.
3.1 Antibacterial materials with good biocompatibility
Biocompatible materials are defined as those that perform their desired functions in an organism without risking tissue damage, cytotoxicity, or rejection by the immune system, and without causing inappropriate local or systemic effects or reducing the ability of the host to respond and interact with living systems (
Nanoparticles, due to their small size and unique properties, are considered to have a high degree of mobility, a variety of proteins, and a strong nucleic acid structure formation in the biological environment, which may enhance or limit several cell functions (
Genipin (GP) is a biological crosslinking agent extracted from the fruit of Gardenia jasminoides that readily forms stable cross-networks and can provide good biocompatibility and low cytotoxicity. A novel nitrogen co-doped carbon dots (CDs)-genipin covalent coupling (N-CDs-GP) compound was synthesized by the hydrothermal method to couple quantum carbon nanomaterial CDs with GP to combine the features of excellent water solubility, high photostability, and low cytotoxicity (
3.2 Antibacterial materials with pro-angiogenic effect
The fracture healing process is affected by the blood supply of the fracture, stability, and the healing site. The influence of nourishing blood vessels, once damaged, will seriously affect the healing of the fracture, and even cause infection (
In original titanium implants, vulnerable to bacterial infection, the effective method to reduce implant failure is to modify the surface of the implant, making it suitable for bone forming cells with simultaneous anti-infective properties. Titanium is combined with the substrate surface by covalent grafting of dopamine, carboxymethyl chitosan (CMCS) or hyaluronic acid-catechins, and VEGF coupling for functional polysaccharide transplantation. CMCS and functional titanium promotes angiogenesis, strengthens the function of osteoblasts, and simultaneously reduces bacterial adhesion (
3.3 Antimicrobial material with osteogenic effect
With the increase of orthopedic implant material use, we face the serious situation of bone infection treatment, and urgently need to improve the osteogenic and antimicrobial capabilities of implantable antimicrobial materials in the application of orthopedic implants, as biological complications such as insufficient bone mass and postoperative infection lead to treatment failure. The implantable material is in direct contact with the bone interface, and the promotion of osteogenesis is key for the antibacterial material to exert its physiological function. However, traditional implantable materials do not have this capability. Emerging antibacterial osteogenesis multifunctional materials are designed to compensate for these shortcomings, in both the osteogenesis phase and in the long-term support of the local structure.
Gallium doped materials enhance the osteogenesis effect in biologically active substances and improve antibacterial activity (
The hydrophilic nature of graphene can lead to enhanced expression of osteogenic genes. One study assembled titanium alloy nanomaterials by using graphitic diyne (GDY) and titanium combined to form titanium alloy nanomaterials. GDY enhances the osteogenic effect by promoting osteoblast adhesion to the nanomaterials, and UV irradiation (365 nm) leads to more ROS production for sterilization (Figure 4A) (
FIGURE 4

(A) Schematic representation of the function of TiO₂/GDY and its application in orthopedic implant infections. (B) Bacterial colony plate counts in implant femoral grinds of the infection model. (C) Quantitative analysis of bacterial colonies in the infection model. *p < 0.0002; **p < 0.0001; ***p < 0.0001). Copyright © 2020, The Author(s). Reproduced with permission (
3.4 Antimicrobial material with coagulation effect
Promotion of the blood-coagulation function of antibacterial material for trauma care is very important, as it prevents acute bleeding to save lives, and prevents bacterial proliferation in the early stage of open or acute tissue injury (
Mesoporous silica is an emerging hemostatic material that absorbs water, promotes clotting factor activation, and assists in biodegradation (
Blood clot formation is composed of platelet activation and aggregation and a multi-step coagulation cascade, which leads to the aggregation of fibrinogen and the formation of a crosslinked fibrin fiber network. The nano fiber structure of can be affected by rapid dehydration, as blood acts as a molecular sieve by producing a mechanical barrier, leading to blood clots. This process accelerates the coagulation cascade and promotes hemostasis (
Recently, studies have used carboxymethyl-copper-carageen glue mixed with poly (vinyl alcohol) nanofibers (PVA-CMKC), to increase blood clotting and antibacterial activity, and promote platelet adhesion and activation (
3.5 Antimicrobial materials with intelligent “kill and release” effects
Traditional antibacterial strategy is divided into two kinds: one is to kill adhering bacteria through the material’s natural bactericidal properties or fungicides (
3.5.1 Intelligent control components: Temperature
A common temperature control switch is poly (N-isopropyl acrylamide) (PNIPAAm), a heat responsive polymer. PNIPAAm modified antibacterial material surfaces have a unique temperature control surface with improved wettability and adhesion performance (
3.5.2 Intelligent control element: pH
pH response polymer poly(methyl acrylic acid) (PMAA) is a weak electrolyte, wherein the charge density and conformation depend on pH. When it is immobilized on the material surface, changes in ambient pH leads to changes in wettability and surface charge, which in turn lead to changes in bio-adhesion to achieve regulation (
FIGURE 5

(A) Schematic diagram of the smart antimicrobial surface, which can function according to pH change. (B) Reversible binding of lysozyme by pH switching of the SiN-PMAA surface. (C) Reversible attachment of E. coli by pH switching on the SiN-PMAA surface. (D) Release of lysozyme in solution when the pH changes from 4 to 7. The inset shows the Si and Si-PMAA surfaces. (E) Comparison of lysozyme release ratios from pH 4 to 7 on antimicrobial surfaces. (F) Comparison of the relative enzymatic activity of free lysozyme at pH 4 and 7. Error bars represent the standard deviation of the mean (n = 3). Copyright © 2016, The Author(s). Reproduced with permission (
There has been a study using a layered structure of polymer brushes to fabricate pH-controlled PMAA and antimicrobial peptide (AMP) dual antimicrobial surfaces (
3.5.3 Intelligent control components: Zwitterion polymer
Zwitterionic polymers refer to those with an equimolar number of anionic and cationic groups evenly distributed along the chain. Zwitterionic compounds with mixed anionic and cationic end groups have strong antifouling properties and are often reported for modification of various surfaces to enhance the hydrophilic, antifouling, and antibacterial properties (
In an aqueous environment, zwitterionic polymers form a hydration layer for significant inhibition of planktonic bacteria adhesion, accumulation of dead bacteria, and drainage. In dry conditions, when the zwitterionic layer collapses, the polycationic layer exhibits bactericidal properties against adherent bacteria (
4 Conclusion and future perspectives
The global orthopedic market is still expanding, and implant placement is a common treatment method therein. Once orthopedic implants become a hiding place for bacteria and infections, bone destruction and bacterial infiltration will occur, and bone regeneration will be insufficient, which will inevitably lead to insufficient local support and the formation of sequestered bones. Despite progress in this field, the development of implantable antimicrobial materials capable of preventing bacterial proliferation is a research challenge that must be overcome due to the decline in antibiotic effectiveness, global superbugs, and antibiotic-resistant bacteria. Therefore, the implant itself requires lasting antibacterial ability and versatility.
We reviewed the latest progress in the field of biomedical antibacterial materials. Firstly, we introduced the respectively organic and inorganic antibacterial and composite materials being used. Antimicrobial materials include the direct and indirect materials against infection. These materials show bactericidal or bacteriostatic activity through slow release of antibacterial agents. However, these materials have some limitations such as: 1) the use of PMMA non-biodegradable material carries that risk of bacterial biofilm; 2) metal ions and particles enter the lymphatic and blood circulation systems, and accumulate in cells and tissues, resulting in cytotoxicity, genotoxicity, and even carcinogenicity; 3) HA and calcium phosphate may be brittle, and not suitable for bearing orthopedic applications; 4) polymer antibacterial activity duration of this biological material is limited, and part of the material depends on antibiotics; and 4) composite materials may reduce cytotoxicity by reducing the concentration of nanoparticles of a single composition, but may still have the limitations of a single material.
Despite the above limitations, the available data for implanting antibacterial material is encouraging. We also outlined currently available antibiotic delivery devices in the application of composite materials. A combination of approaches could be an excellent way to increase the effectiveness of novel antimicrobial materials, and delivery of antibiotics through novel structures and devices could be an excellent option to overcome some practical limitations of commonly used coatings, such as their specificity. We look forward to future research defining an orthopedic antimicrobial biomaterial as that designed to work with permanent orthopedic implants to provide local antimicrobial treatment and maintain implant function.
We also reviewed the most advanced multifunctional antibacterial materials and surfaces. These have biocompatibility, are angiogenesis, osteogenesis, and blood-coagulation promoting, and have “smart killing” capabilities. Biocompatibility materials that properly perform the required function do not result in tissue damage, cell toxicity, risk of rejection, as well as local or systemic effects. They also do not cause undue appropriate host response in the execution of their functions. This is key of the related materials research that cannot be ignored.
These materials must promote angiogenesis of antibacterial material, promote osteogenesis, and help the body create a suitable environment for organization. The process of cell proliferation is essential to promote fracture healing and tissue repair at the surgical site, and antibiotics are often used in implant materials to prevent implant infections. However, excessive use of antibiotics significantly reduces the function of osteoblasts and bone marrow mesenchymal stem cell vitality and proliferation, which will damage the healing process (
Antibacterial materials that promote blood-coagulation function to promote coagulation of organisms, activate endogenous or extrinsic coagulation systems, induce rapid hemostasis, and prevent bacterial proliferation in the early stage of acute tissue injury or open fractures. Bacterial killing and release of specific functions may interfere with each other, usually requiring intelligent switches of function. Intelligent antibacterial surfaces kill the bacteria attached to the surface, and through control of temperature, pH, humidity, or other external factors, such as the stimulating release of dead bacteria and debris, maintain kill efficiency. These processes are efficient and repeatable. Multifunctional materials are constantly being developed, and will be a powerful addition to the complex antibacterial environment we face in the future. Further studies are needed regarding these materials.
At present, part of the antibacterial material model can only be used under laboratory with precision instruments and complex programs. The development thereof requires sustained effort from all researchers to achieve significant progress. Antibacterial material is an important consideration for long-term stability and the ability to maintain implant performance, and the commercialization of the antibacterial material to be used more frequently in the future is very important.
Statements
Author contributions
WS and ZT contributed equally to this work. WS: Conceptualization, investigation, writing—original draft, writing—review and editing. ZT: Conceptualization, investigation, writing—review and editing. ZMl: Conceptualization, writing—review and editing, supervision, project administration, funding acquisition. WG: Conceptualization, writing—review and editing, supervision, project administration, funding acquisition. YY: Writing—review and editing. ZMr: Writing—review and editing. WD: Writing—review and editing. WX: Writing—review and editing. DH: Resources.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AboltinsC.DowseyM.PeelT.LimW. K.ChoongP. (2016). Good quality of life outcomes after treatment of prosthetic joint infection with debridement and prosthesis retention. J. Orthop. Res.34 (5), 898–902. 10.1002/jor.23089
2
Al ThaherY.YangL.JonesS. A.PerniS.ProkopovichP. (2018). LbL-assembled gentamicin delivery system for PMMA bone cements to prolong antimicrobial activity. PLoS One13 (12), e0207753. 10.1371/journal.pone.0207753
3
Al ThaherY.AlotaibiH. F.YangL.ProkopovichP. (2021). PMMA bone cement containing long releasing silica-based chlorhexidine nanocarriers. PLoS One16 (9), e0257947. 10.1371/journal.pone.0257947
4
AlamH. B.PusateriA. E.KindzelskiA.EganD.HootsK.AndrewsM. T.et al (2012). Hypothermia and hemostasis in severe trauma. J. Trauma Acute Care Surg.73 (4), 809–817. 10.1097/ta.0b013e318265d1b8
5
AljohaniS.LayqahL.MasuadiE.Al AlwanB.BaharoonW.GramishJ.et al (2020). Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia. J. Infect. Public Health13 (10), 1576–1579. 10.1016/j.jiph.2020.07.008
6
AndradeG. F.FariaJ. A. Q. A.GomesD. A.de BarrosA. L. B.FernandesR. S.CoelhoA. C. S.et al (2018). Mesoporous silica SBA-16/hydroxyapatite-based composite for ciprofloxacin delivery to bacterial bone infection. J. Sol-Gel Sci. Technol.85 (2), 369–381. 10.1007/s10971-017-4557-y
7
BaranesD.KurtzmanG. M. (2019). Biphasic calcium sulfate as an alternative grafting material in various dental applications. J. Oral Implant.45 (3), 247–255. 10.1563/aaid-joi-d-18-00306
8
BazakaO.BazakaK.TruongV. K.LevchenkoI.JacobM. V.EstrinY.et al (2020). Effect of titanium surface topography on plasma deposition of antibacterial polymer coatings. Appl. Surf. Sci.521, 146375. 10.1016/j.apsusc.2020.146375
9
BeeS.-L.BustamiY.Ul-HamidA.LimK.Abdul HamidZ. A. (2021). Synthesis of silver nanoparticle-decorated hydroxyapatite nanocomposite with combined bioactivity and antibacterial properties. J. Mater Sci. Mater Med.32 (9), 106. 10.1007/s10856-021-06590-y
10
BorkowG.GabbayJ.ZatcoffR. C. (2008). Could chronic wounds not heal due to too low local copper levels?Med. Hypotheses70 (3), 610–613. 10.1016/j.mehy.2007.06.006
11
BoyleK. K.SosaB.OsagieL.TurajaneK.BostromM. P. G.YangX. (2019). Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model. Plos One14 (9), e0222034. 10.1371/journal.pone.0222034
12
BraunJ.EckesS.RommensP. M.SchmitzK.NickelD.RitzU. (2020). Toxic effect of vancomycin on viability and functionality of different cells involved in tissue regeneration. Antibiot. (Basel)9 (5). 10.3390/antibiotics9050238
13
ChanG.MooneyD. J. (2008). New materials for tissue engineering: Towards greater control over the biological response. Trends Biotechnol.26 (7), 382–392. 10.1016/j.tibtech.2008.03.011
14
ChangY.TaiC.-L.HsiehP.-H.UengS. W. N. (2013). Gentamicin in bone cement. Bone & Jt. Res.2 (10), 220–226. 10.1302/2046-3758.210.2000188
15
ChenM.HuJ.HuJ.WangX.QinG.ZhangE. (2021). The osteoimmunomodulatory effect of nanostructured TiFx/TiOx coating on osteogenesis induction. Biomed. Mater.16 (4), 045041. 10.1088/1748-605X/ac0863
16
ChenM.HuY.HouY.LiM.TanL.ChenM.et al (2022). Magnesium/gallium-layered nanosheets on titanium implants mediate osteogenic differentiation of MSCs and osseointegration under osteoporotic condition. Chem. Eng. J.427, 130982. 10.1016/j.cej.2021.130982
17
ChengH.MaoL.XuX.ZengY.LanD.HuH.et al (2015). The bifunctional regulation of interconnected Zn-incorporated ZrO2 nanoarrays in antibiosis and osteogenesis. Biomater. Sci.3 (4), 665–680. 10.1039/c4bm00263f
18
ChengQ.GuoX.HaoX.ShiZ.ZhuS.CuiZ. (2019). Fabrication of robust antibacterial coatings based on an organic-inorganic hybrid system. ACS Appl. Mat. Interfaces11 (45), 42607–42615. 10.1021/acsami.9b15031
19
ChengX.WeiQ.MaY.ShiR.ChenT.WangY.et al (2020). Antibacterial and osteoinductive biomacromolecules composite electrospun fiber. Int. J. Biol. Macromol.143, 958–967. 10.1016/j.ijbiomac.2019.09.156
20
ChiJ.ZhangX.ChenC.ShaoC.ZhaoY.WangY. (2020). Antibacterial and angiogenic chitosan microneedle array patch for promoting wound healing. Bioact. Mater.5 (2), 253–259. 10.1016/j.bioactmat.2020.02.004
21
ChouirfaH.BouloussaH.MigonneyV.Falentin-DaudréC. (2019). Review of titanium surface modification techniques and coatings for antibacterial applications. Acta Biomater.83, 37–54. 10.1016/j.actbio.2018.10.036
22
ChuX.WuF.SunB.ZhangM.SongS.ZhangP.et al (2020). Genipin cross-linked carbon dots for antimicrobial, bioimaging and bacterial discrimination. Colloids Surfaces B Biointerfaces190, 110930. 10.1016/j.colsurfb.2020.110930
23
ClaesL.RecknagelS.IgnatiusA. (2012). Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol.8 (3), 133–143. 10.1038/nrrheum.2012.1
24
CoutoD. S.AlvesN. M.ManoJ. F. (2009). Nanostructured multilayer coatings combining chitosan with bioactive glass nanoparticles. J. Nanosci. Nanotech.9 (3), 1741–1748. 10.1166/jnn.2009.389
25
CrunkhornS. (2018). Gallium fights infection in phase I trial. Nat. Rev. Drug Discov.17 (11), 786. 10.1038/nrd.2018.186
26
CuiL.ZhangJ.ZouJ.YangX.GuoH.TianH.et al (2020). Electroactive composite scaffold with locally expressed osteoinductive factor for synergistic bone repair upon electrical stimulation. Biomaterials230, 119617. 10.1016/j.biomaterials.2019.119617
27
CyphertE. L.von RecumH. A. (2017). Emerging technologies for long-term antimicrobial device coatings: Advantages and limitations. Exp. Biol. Med. (Maywood)242 (8), 788–798. 10.1177/1535370216688572
28
DaiC.YuanY.LiuC.WeiJ.HongH.LiX.et al (2009). Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control. Biomaterials30 (29), 5364–5375. 10.1016/j.biomaterials.2009.06.052
29
DapuntU.Radzuweit-MihaljevicS.LehnerB.HaenschG. M.EwerbeckV. (2016). Bacterial infection and implant loosening in hip and knee arthroplasty: Evaluation of 209 cases. Mater. (Basel)9 (11). 10.3390/ma9110871
30
De GiglioE.CafagnaD.CometaS.AllegrettaA.PedicoA.GiannossaL. C.et al (2013). An innovative, easily fabricated, silver nanoparticle-based titanium implant coating: Development and analytical characterization. Anal. Bioanal. Chem.405 (2), 805–816. 10.1007/s00216-012-6293-z
31
DingD.ZhuQ. (2018). Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. Mater. Sci. Eng. C92, 1041–1060. 10.1016/j.msec.2017.12.036
32
DingX.DuanS.DingX.LiuR.XuF. J. (2018). Versatile antibacterial materials: An emerging arsenal for combatting bacterial pathogens. Adv. Funct. Mater.28 (40). 10.1002/adfm.201802140
33
DingJ.XiaoH.ChenX. (2022). Advanced biosafety materials for prevention and theranostics of biosafety issues. Biosaf. Health4 (2), 59–60. 10.1016/j.bsheal.2022.03.011
34
DongW.ZengQ.YinX.LiuH.LvJ.ZhuL. (2018). Preparation and blood compatibility of electrospun nanofibrous CTS/PLA mats from chitosan nanopowders and poly(lactic acid). Polym. Compos.39 (S1), E416–E425. 10.1002/pc.24500
35
DüringK.PorschP.MahnA.BrinkmannO.GieffersW. (1999). The non-enzymatic microbicidal activity of lysozymes. FEBS Lett.449 (2-3), 93–100. 10.1016/s0014-5793(99)00405-6
36
FischerT. H.ValeriC. R.SmithC. J.ScullC. M.MerricksE. P.NicholsT. C.et al (2008). Non-classical processes in surface hemostasis: Mechanisms for the poly- N -acetyl glucosamine-induced alteration of red blood cell morphology and surface prothrombogenicity. Biomed. Mat.3 (1), 015009. 10.1088/1748-6041/3/1/015009
37
FrançaR.MbehD. A.SamaniT. D.Le TienC.MateescuM. A.YahiaL. H.et al (2013). The effect of ethylene oxide sterilization on the surface chemistry andin vitrocytotoxicity of several kinds of chitosan. J. Biomed. Mat. Res.101 (8), 1444–1455. 10.1002/jbm.b.32964
38
FrankD.CsehG.NagyT.PótóL.KocsisB.MisetaA. (2011). Polymethyl-methacrylate-sorbitol-based capsules as local drug delivery vehicles: A preliminary study. Cell. Biol. Int.35 (5), 499–504. 10.1042/cbi20100712
39
FrazarE. M.ShahR. A.DziublaT. D.HiltJ. Z. (2020). Multifunctional temperature-responsive polymers as advanced biomaterials and beyond. J. Appl. Polym. Sci.137 (25). 10.1002/app.48770
40
GaoW.ThamphiwatanaS.AngsantikulP.ZhangL. (2014). Nanoparticle approaches against bacterial infections. WIREs Nanomed Nanobiotechnol6 (6), 532–547. 10.1002/wnan.1282
41
Garcia-GarciaJ.AzuaraG.OscarF. M.JuliaB.MiguelA.MiguelA.et al (2022). Modification of the polymer of a bone cement with biodegradable microspheres of PLGA and loading with daptomycin and vancomycin improve the response to bone tissue infection. Polym. (Basel)14 (5). 10.3390/polym14050888
42
Giri DevV. R.HemamaliniT. (2018). Porous electrospun starch rich polycaprolactone blend nanofibers for severe hemorrhage. Int. J. Biol. Macromol.118, 1276–1283. 10.1016/j.ijbiomac.2018.06.163
43
González-SánchezM. I.PerniS.TommasiG.MorrisN. G.HawkinsK.López-CabarcosE.et al (2015). Silver nanoparticle based antibacterial methacrylate hydrogels potential for bone graft applications. Mater. Sci. Eng. C50, 332–340. 10.1016/j.msec.2015.02.002
44
GulerS.OzsekerE. E.AkkayaA. (2016). Developing an antibacterial biomaterial. Eur. Polym. J.84, 326–337. 10.1016/j.eurpolymj.2016.09.031
45
HasanJ.ChatterjeeK. (2015). Recent advances in engineering topography mediated antibacterial surfaces. Nanoscale7 (38), 15568–15575. 10.1039/c5nr04156b
46
HeW.ZhouY.-T.WamerW. G.BoudreauM. D.YinJ.-J. (2012). Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles. Biomaterials33 (30), 7547–7555. 10.1016/j.biomaterials.2012.06.076
47
HornyákI.EditM.LaczaZ.HanW.PalmaK.VaczG.et al (2014). Increased release time of antibiotics from bone allografts through a novel biodegradable coating. BioMed Res. Int.2014, 459867. 10.1155/2014/459867
48
HouchinM. L.ToppE. M. (2009). Physical properties of PLGA films during polymer degradation. J. Appl. Polym. Sci.114 (5), 2848–2854. 10.1002/app.30813
49
HuX.NeohK.-G.ShiZ.KangE.-T.PohC.WangW. (2010). An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion. Biomaterials31 (34), 8854–8863. 10.1016/j.biomaterials.2010.08.006
50
HuR.LiG.JiangY.ZhangY.ZouJ.-J.WangL.et al (2013). Silver-zwitterion organic-inorganic nanocomposite with antimicrobial and antiadhesive capabilities. Langmuir29 (11), 3773–3779. 10.1021/la304708b
51
HughesE.YanniT.JamshidiP.GroverL. M. (2015). Inorganic cements for biomedical application: Calcium phosphate, calcium sulphate and calcium silicate. Adv. Appl. Ceram.114 (2), 65–76. 10.1179/1743676114y.0000000219
52
IshikawaM.de Mesy BentleyK. L.McEntireB. J.BalB. S.SchwarzE. M.XieC. (2017). Surface topography of silicon nitride affects antimicrobial and osseointegrative properties of tibial implants in a murine model. J. Biomed. Mat. Res.105 (12), 3413–3421. 10.1002/jbm.a.36189
53
JaggessarA.ShahaliH.MathewA.YarlagaddaP. K. D. V. (2017). Bio-mimicking nano and micro-structured surface fabrication for antibacterial properties in medical implants. J. Nanobiotechnol15 (1), 64. 10.1186/s12951-017-0306-1
54
JiangP. J.PatelS.GbureckU.GroverL. M. (2007). A Comparison of the efficacy of hydoxyapatite based cements and gels as drug delivery matrices. Kem361-363, 327–330. 10.4028/www.scientific.net/kem.361-363.327
55
JiangZ.LiuY.ShiR.FengX.XuW.ZhuangX.et al (2022). Versatile polymer‐initiating biomineralization for tumor blockade therapy. Adv. Mater.34 (19), 2110094. 10.1002/adma.202110094
56
JiaoJ.ZhangS.QuX.YueB. (2021). Recent advances in research on antibacterial metals and alloys as implant materials. Front. Cell Infect. Microbiol.11, 693939. 10.3389/fcimb.2021.693939
57
JoyceK.FabraG. T.BozkurtY.PanditA. (2021). Bioactive potential of natural biomaterials: Identification, retention and assessment of biological properties. Sig Transduct. Target Ther.6 (1), 122. 10.1038/s41392-021-00512-8
58
KapadiaN. P. (2005). “Effect of endotoxin and silver ion on the clotting time of blood,” in IEEE 31st annual Northeast bioengineering conference (Hoboken, NJ: Stevens Inst Technol).
59
KeenanT. J.PlacekL. M.HallM. M.WrenA. W. (2017). Antibacterial and antifungal potential of Ga-bioactive glass and Ga-bioactive glass/polymeric hydrogel composites. J. Biomed. Mat. Res.105 (5), 1102–1113. 10.1002/jbm.b.33655
60
KimT. G.ShinH.LimD. W. (2012). Biomimetic scaffolds for tissue engineering. Adv. Funct. Mat.22 (12), 2446–2468. 10.1002/adfm.201103083
61
KimJ.LeeM. U.KimT.-H. (2019). Nationwide epidemiologic study for pediatric osteomyelitis and septic arthritis in South Korea. Medicine98 (17), e15355. 10.1097/md.0000000000015355
62
KimnaC.DegerS.TamburaciS.TihminliogluF. (2019). Chitosan/montmorillonite composite nanospheres for sustained antibiotic delivery at post-implantation bone infection treatment. Biomed. Mater14 (4), 044101. 10.1088/1748-605X/ab1a04
63
KoseN.ÇaylakR.PekşenC.KiremitçiA.BurukogluD.KoparalS.et al (2016). Silver ion doped ceramic nano-powder coated nails prevent infection in open fractures: In vivo study. Injury47 (2), 320–324. 10.1016/j.injury.2015.10.006
64
KremersH. M.NwojoM. E.RansomJ. E.Wood-WentzC. M.MeltonL. J.HuddlestonP. M. (2015). Trends in the epidemiology of osteomyelitis. J. Bone Jt. Surg.97 (10), 837–845. 10.2106/jbjs.n.01350
65
KrishnadossV.MelilloA.KanjilalB.HannahT.EllisE.KapetanakisA.et al (2019). Bioionic liquid conjugation as universal approach to engineer hemostatic bioadhesives. ACS Appl. Mat. Interfaces11 (42), 38373–38384. 10.1021/acsami.9b08757
66
KumarS.ShayorajS.DeviN.DubeyS. K.KumarA.KumarS.et al (2021). Preparation, characterization and properties of some acrylic base latex: A review. Orient. J. Chem.37 (5), 1002–1016. 10.13005/ojc/370501
67
KwonH. J.LeeY.PhuongL. T.SeonG. M.KimE.ParkJ. C.et al (2017). Zwitterionic sulfobetaine polymer-immobilized surface by simple tyrosinase-mediated grafting for enhanced antifouling property. Acta Biomater.61, 169–179. 10.1016/j.actbio.2017.08.007
68
LaiP. L.ChuI.-M.ChenL.-H.ChenW.-J. (2013). Chemical and physical properties of bone cement for vertebroplasty. Biomed. J.36 (4), 162–167. 10.4103/2319-4170.112750
69
LaycockP. A.CooperJ. J.HowlinR. P.DeluryC.AikenS.StoodleyP. (2018). In vitro efficacy of antibiotics released from calcium sulfate bone void filler beads. Mater. (Basel)11 (11). 10.3390/ma11112265
70
Leslie-BarbickJ. E.MoonJ. J.WestJ. L. (2009). Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels. J. Biomaterials Sci. Polym. Ed.20 (12), 1763–1779. 10.1163/156856208x386381
71
LiY.LiuX.TanL.RenL.WanP.HaoY.et al (2016). Enoxacin-loaded poly (lactic-co-glycolic acid) coating on porous magnesium scaffold as a drug delivery system: Antibacterial properties and inhibition of osteoclastic bone resorption. J. Mater. Sci. Technol.32 (9), 865–873. 10.1016/j.jmst.2016.07.013
72
LiK.CaiK.RanQ.JiangD. (2019). Biomimetic triphase composite scaffolds with antibacterial and anti-tumor potentials for bone repair. Mater. Lett.256, 126590. 10.1016/j.matlet.2019.126590
73
LiD.WeiQ.WuC.ZhangX.XueQ.ZhengT.et al (2020). Superhydrophilicity and strong salt-affinity: Zwitterionic polymer grafted surfaces with significant potentials particularly in biological systems. Adv. Colloid Interface Sci.278, 102141. 10.1016/j.cis.2020.102141
74
LianX.MaoK.LiuX.WangX.CuiF. (2015). In vivo osteogenesis of vancomycin loaded nanohydroxyapatite/collagen/calcium sulfate composite for treating infectious bone defect induced by chronic osteomyelitis. J. Nanomater.2015, 261492. 10.1155/2015/261492
75
LiuZ.DavisC.CaiW.HeL.ChenX.DaiH. (2008). Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. U.S.A.105 (5), 1410–1415. 10.1073/pnas.0707654105
76
LiuY.ZhengZ.ZaraJ. N.HsuC.SooferD. E.LeeK. S.et al (2012). The antimicrobial and osteoinductive properties of silver nanoparticle/poly (dl-lactic-co-glycolic acid)-coated stainless steel. Biomaterials33 (34), 8745–8756. 10.1016/j.biomaterials.2012.08.010
77
LuZ.GaoJ.HeQ.WuJ.LiangD.YangH.et al (2017). Enhanced antibacterial and wound healing activities of microporous chitosan-Ag/ZnO composite dressing. Carbohydr. Polym.156, 460–469. 10.1016/j.carbpol.2016.09.051
78
LuoH. L.XiaoJ.PengM.ZhangQ.YangZ.WanY.et al (2020). One-pot synthesis of copper-doped mesoporous bioglass towards multifunctional 3D nanofibrous scaffolds for bone regeneration. J. Non-Crystalline Solids, 532. 10.1016/j.jnoncrysol.2019.119856
79
MadrugaL. Y. C.SabinoR. M.SantosE. C. G.PopatK. C.BalabanR. d. C.KipperM. J. (2020). Carboxymethyl-kappa-carrageenan: A study of biocompatibility, antioxidant and antibacterial activities. Int. J. Biol. Macromol.152, 483–491. 10.1016/j.ijbiomac.2020.02.274
80
MadrugaL. Y. C.PopatK. C.BalabanR. C.KipperM. J. (2021). Enhanced blood coagulation and antibacterial activities of carboxymethyl-kappa-carrageenan-containing nanofibers. Carbohydr. Polym.273, 118541. 10.1016/j.carbpol.2021.118541
81
MaidaniucA.MiculescuM.VoicuS. I.CiocanL. T.NiculescuM.CorobeaM. C.et al (2016). Effect of micron sized silver particles concentration on the adhesion induced by sintering and antibacterial properties of hydroxyapatite microcomposites. J. Adhesion Sci. Technol.30 (17), 1829–1841. 10.1080/01694243.2016.1163808
82
MakvandiP.AliG. W.Della SalaF.Abdel-FattahW. I.BorzacchielloA. (2020). Hyaluronic acid/corn silk extract based injectable nanocomposite: A biomimetic antibacterial scaffold for bone tissue regeneration. Mater. Sci. Eng. C107, 110195. 10.1016/j.msec.2019.110195
83
MalizosK. N. (2017). Global forum: The burden of bone and joint infections. J. Bone Jt. Surg.99 (5), e20. 10.2106/jbjs.16.00240
84
MaryP.BendejacqD. D.LabeauM.-P.DupuisP. (2007). Reconciling low- and high-salt solution behavior of sulfobetaine polyzwitterions. J. Phys. Chem. B111 (27), 7767–7777. 10.1021/jp071995b
85
MatosA. C.RibeiroI. A.GuedesR. C.PintoR.VazM. A.GonçalvesL. M.et al (2015). Key-properties outlook of a levofloxacin-loaded acrylic bone cement with improved antibiotic delivery. Int. J. Pharm.485 (1-2), 317–328. 10.1016/j.ijpharm.2015.03.035
86
MazurK.SinghR.CichaI.KucielS.BoguckiR.UnterwegerH.et al (2020). The effect of antibacterial particle incorporation on the mechanical properties, biodegradability, and biocompatibility of PLA and PHBV composites. Macromol. Mater. Eng.305 (9). 10.1002/mame.202000244
87
McConougheyS. J.HowlinR. P.WisemanJ.StoodleyP.CalhounJ. H. (2015). Comparing PMMA and calcium sulfate as carriers for the local delivery of antibiotics to infected surgical sites. J. Biomed. Mat. Res.103 (4), 870–877. 10.1002/jbm.b.33247
88
MillsL.TsangJ.HopperG.KeenanG.SimpsonA. H. R. W. (2016). The multifactorial aetiology of fracture nonunion and the importance of searching for latent infection. Bone & Jt. Res.5 (10), 512–519. 10.1302/2046-3758.510.bjr-2016-0138
89
MistryS.RoyS.MaitraN. J.KunduB.ChandaA.DattaS.et al (2016). A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model. J. Control. Release239, 169–181. 10.1016/j.jconrel.2016.08.014
90
MiyanoY.KoyamaK.SreekumariK. R.SatoY.KikuchiY. (2007). Evaluation of antibacterial ability of some pure metals. Tetsu-to-Hagane93 (1), 57–65. 10.2355/tetsutohagane.93.57
91
Mohan RajR.DuraisamyN.RajV. (2022). Drug loaded chitosan/aloe vera nanocomposite on Ti for orthopedic applications. Mater. Today Proc.51, 1714–1719. 10.1016/j.matpr.2020.10.772
92
MoradiM.SongZ.NieX.YanM.HuF. Q. (2016). Investigation of bacterial attachment and biofilm formation of two different Pseudoalteromonas species: Comparison of different methods. Int. J. Adhesion Adhesives65, 70–78. 10.1016/j.ijadhadh.2015.11.004
93
MurilloO.GrauI.Lora-TamayoJ.Gomez-JunyentJ.RiberaA.TubauF.et al (2015). The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century. Clin. Microbiol. Infect.21 (3), 254–258. 10.1016/j.cmi.2014.09.007
94
NagaseK. (2021). Thermoresponsive interfaces obtained using poly(N-isopropylacrylamide)-based copolymer for bioseparation and tissue engineering applications. Adv. Colloid Interface Sci.295, 102487. 10.1016/j.cis.2021.102487
95
NakashimaT.MatsuoM.BinY.NakanoY.KobayashiT.KomemushiS.et al (2006). Mechanical properties and antibacterial efficacy of chitosan films. Biocontrol Sci.11 (1), 27–36. 10.4265/bio.11.27
96
NakielskiP.PieriniF. (2019). Blood interactions with nano- and microfibers: Recent advances, challenges and applications in nano- and microfibrous hemostatic agents. Acta Biomater.84, 63–76. 10.1016/j.actbio.2018.11.029
97
NegimE. S. M.NurpeissovaZ. A.MangazbayevaR. A.KhatibJ. M.WilliamsC.MunG. A. (2014). Effect of pH on the physico-mechanical properties and miscibility of methyl cellulose/poly(acrylic acid) blends. Carbohydr. Polym.101, 415–422. 10.1016/j.carbpol.2013.09.047
98
NikolovaM. P.ChavaliM. S. (2019). Recent advances in biomaterials for 3D scaffolds: A review. Bioact. Mater.4, 271–292. 10.1016/j.bioactmat.2019.10.005
99
NogueiraT.BotanR.Macedo NetoJ. C.WypychF.LonaL. (2013). Effect of layered double hydroxides on the mechanical, thermal, and fire properties of poly(methyl methacrylate) nanocomposites. Adv. Polym. Technol.32 (S1), E660–E674. 10.1002/adv.21309
100
OeiJ. D.ZhaoW. W.ChuL.DeSilvaM. N.GhimireA.RawlsH. R.et al (2012). Antimicrobial acrylic materials with in situ generated silver nanoparticles. J. Biomed. Mat. Res.100B (2), 409–415. 10.1002/jbm.b.31963
101
OrdikhaniF.SimchiA. (2014). Long-term antibiotic delivery by chitosan-based composite coatings with bone regenerative potential. Appl. Surf. Sci.317, 56–66. 10.1016/j.apsusc.2014.07.197
102
PahlevanzadehF.Bakhsheshi-RadH. R.Kasiri-AsgaraniM.EmadiR.OmidiM.IsmailA. F.et al (2021). Mechanical property, antibacterial activity and cytocompatibility of a PMMA-based bone cement loaded with clindamycin for orthopaedic surgeries. Mater. Technol.36 (9), 564–573. 10.1080/10667857.2020.1780812
103
ParisJ.-B.SeyerD.JouenneT.ThébaultP. (2017). Elaboration of antibacterial plastic surfaces by a combination of antiadhesive and biocidal coatings of natural products. Colloids Surfaces B Biointerfaces156, 186–193. 10.1016/j.colsurfb.2017.05.025
104
ParisJ.-B.SeyerD.JouenneT.ThébaultP. (2019). Various methods to combine hyaluronic acid and antimicrobial peptides coatings and evaluation of their antibacterial behaviour. Int. J. Biol. Macromol.139, 468–474. 10.1016/j.ijbiomac.2019.07.188
105
PasseriniN.CraigD. Q. M. (2001). An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. J. Control. Release73 (1), 111–115. 10.1016/s0168-3659(01)00245-0
106
PhilpA. M.RajaS.PhilpA.Newton EdeM. P.JonesS. W. (2017). The effect of vancomycin and gentamicin antibiotics on human osteoblast proliferation, metabolic function, and bone mineralization. Spine (Phila Pa 1976)42 (3), 202–207. 10.1097/BRS.0000000000001712
107
PinhoA. C.PiedadeA. P. (2020). Polymeric coatings with antimicrobial activity: A short review. Polym. (Basel)12 (11). 10.3390/polym12112469
108
PiuzziN. S.NgM.SongS.BigachS.KhlopasA.Salas-VegaS.et al (2019). Consolidation and maturation of the orthopaedic medical device market between 1999 and 2015. Eur. J. Orthop. Surg. Traumatol.29 (4), 759–766. 10.1007/s00590-019-02372-z
109
PorrinoJ.WangA.MoatsA.MulcahyH.KaniK. (2020). Prosthetic joint infections: Diagnosis, management, and complications of the two-stage replacement arthroplasty. Skelet. Radiol.49 (6), 847–859. 10.1007/s00256-020-03389-w
110
PriceA. J.AlvandA.TroelsenA.KatzJ. N.HooperG.GrayA.et al (2018). Knee replacement. Lancet392 (10158), 1672–1682. 10.1016/s0140-6736(18)32344-4
111
QinT.LópezA.ÖhmanC.EngqvistH.PerssonC.XiaW. (2015). Enhanced drug delivery of antibiotic-loaded acrylic bone cements using calcium phosphate spheres. J. Appl. Biomater. Funct. Mater13 (3), e241–e247. 10.5301/jabfm.5000222
112
QinX.-H.LabudaK.ChenJ.HruschkaV.KhademA.LiskaR.et al (2015). Development of synthetic platelet-activating hydrogel matrices to induce local hemostasis. Adv. Funct. Mat.25 (42), 6606–6617. 10.1002/adfm.201501637
113
QinY.LiP.GuoZ. (2020). Cationic chitosan derivatives as potential antifungals: A review of structural optimization and applications. Carbohydr. Polym.236, 116002. 10.1016/j.carbpol.2020.116002
114
QiuX.LiS.LiX.XiaoY.LiS.FenQ.et al (2022). Experimental study of β-TCP scaffold loaded with VAN/PLGA microspheres in the treatment of infectious bone defects. Colloids Surfaces B Biointerfaces213, 112424. 10.1016/j.colsurfb.2022.112424
115
RamachandranB.MuthuvijayanV. (2019). “Surface engineering approaches for controlling biofilms and wound infections,” in Introduction to biofilm engineering. Editors RathinamN. K.SaniR. K., 101–123. 10.1021/bk-2019-1323.ch005
116
RaoH.LuZ.LiuW.WangY.GeH.ZouP.et al (2016). The adsorption of bone-related proteins on calcium phosphate ceramic particles with different phase composition and its adsorption kinetics. Surf. Interface Anal.48 (10), 1048–1055. 10.1002/sia.6021
117
RizzelloL.CingolaniR.PompaP. P. (2013). Nanotechnology tools for antibacterial materials. Nanomedicine8 (5), 807–821. 10.2217/nnm.13.63
118
Rojas-AndradeM. D.ChataG.RouholimanD.LiuJ.SaltikovC.ChenS. (2017). Antibacterial mechanisms of graphene-based composite nanomaterials. Nanoscale9 (3), 994–1006. 10.1039/c6nr08733g
119
RomanòC. L.VecchiE. D.BortolinM.MorelliI.DragoL. (2017). Hyaluronic acid and its composites as a local antimicrobial/antiadhesive barrier. J. Bone Jt. Infect.2 (1), 63–72. 10.7150/jbji.17705
120
RossatoA. M.ReiterK. C.SoaresR. O.PaimT. G. d. S.SambranoG. E.D’ AzevedoP. A. (2018). Características moleculares de Staphylococcus aureus suscetível à vancomicina poderia ajudar a prever falhas no tratamento devido à reduzida suscetibilidade à vancomicina. Rev. Epidemiol. Control Infect.8 (4), 422–427. 10.17058/reci.v8i4.11393
121
SahariahP.MássonM. (2017). Antimicrobial chitosan and chitosan derivatives: A review of the structure-activity relationship. Biomacromolecules18 (11), 3846–3868. 10.1021/acs.biomac.7b01058
122
Sanchez-SalcedoS.MalavasiG.SalinasA. J.LusvardiG.RigamontiL.MenabueL.et al (2018). Highly-bioreactive silica-based mesoporous bioactive glasses enriched with gallium(III). Mater. (Basel)11 (3). 10.3390/ma11030367
123
SargeantA.GoswamiT. (2007). Hip implants - paper VI - ion concentrations. Mater. Des.28 (1), 155–171. 10.1016/j.matdes.2005.05.018
124
SatolaS. W.FarleyM. M.AndersonK. F.PatelJ. B. (2011). Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J. Clin. Microbiol.49 (1), 177–183. 10.1128/jcm.01128-10
125
SchantéC. E.ZuberG.HerlinC.VandammeT. F. (2011). Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr. Polym.85 (3), 469–489. 10.1016/j.carbpol.2011.03.019
126
SciallaS.MartuscelliG.NappiF.SinghS. S. A.IervolinoA.LarobinaD.et al (2021). Trends in managing cardiac and orthopaedic device-associated infections by using therapeutic biomaterials. Polym. (Basel)13 (10). 10.3390/polym13101556
127
ShenX.ZhangY.MaP.SutrisnoL.LuoZ.HuY.et al (2019). Fabrication of magnesium/zinc-metal organic framework on titanium implants to inhibit bacterial infection and promote bone regeneration. Biomaterials212, 1–16. 10.1016/j.biomaterials.2019.05.008
128
ShenY.-F.HuangJ.-H.WuZ.-E.WangK.-Y.ZhengJ.CaiL.et al (2020). Cationic superabsorbent hydrogel composed of mesoporous silica as a potential haemostatic material. Mater. Sci. Eng. C111, 110841. 10.1016/j.msec.2020.110841
129
SinM.-C.ChenS.-H.ChangY. (2014). Hemocompatibility of zwitterionic interfaces and membranes. Polym. J.46 (8), 436–443. 10.1038/pj.2014.46
130
SongF.KooH.RenD. (2015). Effects of material properties on bacterial adhesion and biofilm formation. J. Dent. Res.94 (8), 1027–1034. 10.1177/0022034515587690
131
StevanovicM.DjosicM.JankovicA.RheeK.Miskovic-StankovicV. (2019). Electrophoretically deposited hydroxyapatite-based composite coatings loaded with silver and gentamicin as antibacterial agents. Jscs84 (11), 1287–1304. 10.2298/jsc190821092s
132
StigterM.BezemerJ.de GrootK.LayrolleP. (2004). Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J. Control. Release99 (1), 127–137. 10.1016/j.jconrel.2004.06.011
133
SungkhaphanP.JanvikulW.SorayaP.VeerachaiP.WeerachaiS.BoonlomT.et al (2021). Antibacterial and osteogenic activities of clindamycin-releasing mesoporous silica/carboxymethyl chitosan composite hydrogels. R. Soc. Open Sci.8 (9), 210808. 10.1098/rsos.210808
134
TeskeS. S.DetweilerC. S. (2015). The biomechanisms of metal and metal-oxide nanoparticles' interactions with cells. Ijerph12 (2), 1112–1134. 10.3390/ijerph120201112
135
TîlmaciuC. M.MathieuM.LavigneJ.-P.ToupetK.GuerreroG.PoncheA.et al (2015). In vitro and in vivo characterization of antibacterial activity and biocompatibility: A study on silver-containing phosphonate monolayers on titanium. Acta Biomater.15, 266–277. 10.1016/j.actbio.2014.12.020
136
TurnerJ. G.WhiteL. R.EstrelaP.LeeseH. S. (2021). Hydrogel-forming microneedles: Current advancements and future trends. Macromol. Biosci.21 (2), e2000307. 10.1002/mabi.202000307
137
UengS. W.LinS.-S.WangI.-C.YangC.-Y.ChengR.-C.LiuS.-J.et al (2016). Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus. J. Orthop. Surg. Res.11 (1), 52. 10.1186/s13018-016-0386-x
138
van HengelI. A. J.PutraN. E.TierolfM. W. A. M.MinnebooM.FluitA. C.Fratila-ApachiteiL. E.et al (2020). Biofunctionalization of selective laser melted porous titanium using silver and zinc nanoparticles to prevent infections by antibiotic-resistant bacteria. ACTA BIOMATER.107, 325–337. 10.1016/j.actbio.2020.02.044
139
VerronE.LoubatA.CarleG. F.Vignes-ColombeixC.StrazicI.GuicheuxJ.et al (2012). Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes. Biochem. Pharmacol.83 (5), 671–679. 10.1016/j.bcp.2011.12.015
140
WalterN.BaertlS.AltV.RuppM. (2021). What is the burden of osteomyelitis in Germany? An analysis of inpatient data from 2008 through 2018. BMC Infect. Dis.21 (1), 550. 10.1186/s12879-021-06274-6
141
WangX.ChengF.LiuJ.SmåttJ.-H.GepperthD.LastusaariM.et al (2016). Biocomposites of copper-containing mesoporous bioactive glass and nanofibrillated cellulose: Biocompatibility and angiogenic promotion in chronic wound healing application. Acta Biomater.46, 286–298. 10.1016/j.actbio.2016.09.021
142
WangQ.DingC.ZhouY.luoJ.LiJ. (2018). Universal and biocompatible hydroxyapatite coating induced by phytic acid-metal complex multilayer. Colloids Surfaces B Biointerfaces169, 478–485. 10.1016/j.colsurfb.2018.05.057
143
WangJ.PengC.ChenZ.SunS.ShiZ.JinL.et al (2019). Engineering antimicrobial and biocompatible electrospun PLGA fibrous membranes by irradiation grafting polyvinylpyrrolidone and periodate. Colloids Surfaces B Biointerfaces181, 918–926. 10.1016/j.colsurfb.2019.06.059
144
WangC.NiuH.MaX.HongH.YuanY.LiuC. (2019). Bioinspired, injectable, quaternized hydroxyethyl cellulose composite hydrogel coordinated by mesocellular silica foam for rapid, noncompressible hemostasis and wound healing. ACS Appl. Mat. Interfaces11 (38), 34595–34608. 10.1021/acsami.9b08799
145
WangR.ShiM.XuF.QiuY.ZhangP.ShenK.et al (2020). Graphdiyne-modified TiO2 nanofibers with osteoinductive and enhanced photocatalytic antibacterial activities to prevent implant infection. Nat. Commun.11 (1), 4465. 10.1038/s41467-020-18267-1
146
WangR.ShiM.XuF.QiuY.ZhangP.ShenK.et al (2020). Graphdiyne-modified TiO2 nanofibers with osteoinductive and enhanced photocatalytic antibacterial activities to prevent implant infection. Nat. Commun.11 (1), 4465. 10.1038/s41467-020-18267-1
147
WeiT.YuQ.ZhanW.ChenH. (2016). A smart antibacterial surface for the on-demand killing and releasing of bacteria. Adv. Healthc. Mat.5 (4), 449–456. 10.1002/adhm.201500700
148
WeiT.TangZ.YuQ.ChenH. (2017). Smart antibacterial surfaces with switchable bacteria-killing and bacteria-releasing capabilities. ACS Appl. Mat. Interfaces9 (43), 37511–37523. 10.1021/acsami.7b13565
149
WeiT.YuQ.ChenH. (2019). Responsive and synergistic antibacterial coatings: Fighting against bacteria in a smart and effective way. Adv. Healthc. Mater8 (3), e1801381. 10.1002/adhm.201801381
150
WeiQ.SuY.XinH.ZhangL.DingJ.ChenX. (2021). Immunologically effective biomaterials. ACS Appl. Mat. Interfaces13 (48), 56719–56724. 10.1021/acsami.1c14781
151
WickramasingheS.JuM.MilbrandtN. B.TsaiY. H.Navarreto-LugoM.VisperasA.et al (2020). Photoactivated gold nanorod hydrogel composite containing D-amino acids for the complete eradication of bacterial biofilms on metal alloy implant materials. ACS Appl. Nano Mat.3 (6), 5862–5873. 10.1021/acsanm.0c01018
152
WilliamsD. F. (2008). On the mechanisms of biocompatibility. Biomaterials29 (20), 2941–2953. 10.1016/j.biomaterials.2008.04.023
153
WilliamsD. F. (2017). Biocompatibility pathways: Biomaterials-induced sterile inflammation, mechanotransduction, and principles of biocompatibility control. ACS Biomater. Sci. Eng.3 (1), 2–35. 10.1021/acsbiomaterials.6b00607
154
WuC.ZhouY.XuM.HanP.ChenL.ChangJ.et al (2013). Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials34 (2), 422–433. 10.1016/j.biomaterials.2012.09.066
155
WuL.GuY.LiuL.TangJ.MaoJ.XiK.et al (2020). Hierarchical micro/nanofibrous membranes of sustained releasing VEGF for periosteal regeneration. Biomaterials227, 119555. 10.1016/j.biomaterials.2019.119555
156
XiangY.XuR.-G.LengY. (2018). Molecular simulations of the hydration behavior of a zwitterion brush array and its antifouling property in an aqueous environment. Langmuir34 (6), 2245–2257. 10.1021/acs.langmuir.7b03386
157
XueY.XiaoH. N.ZhangY. (2015). Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts. Ijms16 (2), 3626–3655. 10.3390/ijms16023626
158
YamaguchiS.Thi Minh LeP.ItoM.ShintaniS. A.TakadamaH. (2019). Tri-functional calcium-deficient calcium titanate coating on titanium metal by chemical and heat treatment. Coatings9 (9), 561. 10.3390/coatings9090561
159
YanS.LuanS.ShiH.XuX.ZhangJ.YuanS.et al (2016). Hierarchical polymer brushes with dominant antibacterial mechanisms switching from bactericidal to bacteria repellent. Biomacromolecules17 (5), 1696–1704. 10.1021/acs.biomac.6b00115
160
YanC.YangT.ZhuS.WuH. (2017). Synthesis and properties of poly(DEX-GMA/AAc) microgel particle as a hemostatic agent. J. Mat. Chem. B5 (20), 3697–3705. 10.1039/c7tb00768j
161
YangY.YangS.WangY.YuZ.AoH.ZhangH.et al (2016). Anti-infective efficacy, cytocompatibility and biocompatibility of a 3D-printed osteoconductive composite scaffold functionalized with quaternized chitosan. Acta Biomater.46, 112–128. 10.1016/j.actbio.2016.09.035
162
YangH.SongL.ZouY.SunD.WangL.YuZ.et al (2021). Role of hyaluronic acids and potential as regenerative biomaterials in wound healing. ACS Appl. Bio Mat.4 (1), 311–324. 10.1021/acsabm.0c01364
163
YangJ.WangY.WangZ.GaoY.YangE.WangW.et al (2022). Efficient sterilization system combining flavonoids and hyaluronic acid with metal organic frameworks as carrier. J. Biomed. Mater. Res. Part B Appl. Biomaterials110. 10.1002/jbm.b.35046
164
YuQ.IstaL. K.LópezG. P. (2014). Nanopatterned antimicrobial enzymatic surfaces combining biocidal and fouling release properties. Nanoscale6 (9), 4750–4757. 10.1039/c3nr06497b
165
YuQ.GeW.AtewologunA.LópezG. P.Stiff-RobertsA. D. (2014). RIR-MAPLE deposition of multifunctional films combining biocidal and fouling release properties. J. Mat. Chem. B2 (27), 4371–4378. 10.1039/c4tb00566j
166
ZengQ.ZhuY.YuB.SunY.DingX.XuC.et al (2018). Antimicrobial and antifouling polymeric agents for surface functionalization of medical implants. Biomacromolecules19 (7), 2805–2811. 10.1021/acs.biomac.8b00399
167
ZhangS.XuK.DarabiM. A.YuanQ.XingM. (2016). Mussel-inspired alginate gel promoting the osteogenic differentiation of mesenchymal stem cells and anti-infection. Mater. Sci. Eng. C69, 496–504. 10.1016/j.msec.2016.06.044
168
ZhangP.QinJ.ZhangB.ZhengY.YangL.ShenY.et al (2019). Gentamicin-loaded silk/nanosilver composite scaffolds for MRSA-induced chronic osteomyelitis. R. Soc. Open Sci.6 (5), 182102. 10.1098/rsos.182102
169
ZhangY.LiT.-T.ShiuB.-C.LinJ.-H.LouC.-W. (2021). Two methods for constructing ZIF-8 nanomaterials with good bio compatibility and robust antibacterial applied to biomedical. J. Biomater. Appl.36 (6), 1042–1054. 10.1177/08853282211033682
170
ZhangJ.TongD.SongH.RuanR.SunY.LinY.et al (2022). Osteoimmunity‐regulating biomimetically hierarchical scaffold for augmented bone regeneration. Adv. Mater.34 (36), 2202044. 10.1002/adma.202202044
171
ZhaoL.WangH.HuoK.CuiL.ZhangW.NiH.et al (2011). Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials32 (24), 5706–5716. 10.1016/j.biomaterials.2011.04.040
172
ZhaoQ.YiL.JiangL.MaY.LinH.DongJ. (2019). Osteogenic activity and antibacterial ability on titanium surfaces modified with magnesium-doped titanium dioxide coating. Nanomedicine14 (9), 1109–1133. 10.2217/nnm-2018-0413
173
ZhouX.WengW.ChenB.FengW.WangW.NieW.et al (2018). Mesoporous silica nanoparticles/gelatin porous composite scaffolds with localized and sustained release of vancomycin for treatment of infected bone defects. J. Mat. Chem. B6 (5), 740–752. 10.1039/c7tb01246b
174
ZhuW.WangD.PengL.ZhangX.OuY.FenW.et al (2013). An experimental study on the application of radionuclide imaging in repairing bone defects. Artif. Cells, Nanomedicine, Biotechnol.41 (5), 304–308. 10.3109/10731199.2012.742098
175
ZhuM.FangJ.LiY.ZhongC.FengS.GeX.et al (2021). The synergy of topographical micropatterning and Ta|TaCu bilayered thin film on titanium implants enables dual‐functions of enhanced osteogenesis and anti‐infection. Adv. Healthc. Mat.10 (9), 2002020. 10.1002/adhm.202002020
176
ZhuT.JiangM.ZhangM.CuiL.YangX.WangX.et al (2022). Construction and validation of steroid-induced rabbit osteonecrosis model. MethodsX9, 101713. 10.1016/j.mex.2022.101713
Summary
Keywords
biological materials, bone infection, multifunctional material, implantable material, treatment of bone infection, progress of infection treatment, multifunctionalization of materials
Citation
Shuaishuai W, Tongtong Z, Dapeng W, Mingran Z, Xukai W, Yue Y, Hengliang D, Guangzhi W and Minglei Z (2023) Implantable biomedical materials for treatment of bone infection. Front. Bioeng. Biotechnol. 11:1081446. doi: 10.3389/fbioe.2023.1081446
Received
27 October 2022
Accepted
18 January 2023
Published
30 January 2023
Volume
11 - 2023
Edited by
Xiaoyuan Li, Northeast Normal University, China
Reviewed by
Fuzeng Ren, Southern University of Science and Technology, China
Gong Cheng, Harvard University, United States
Ruogu Qi, Nanjing University of Chinese Medicine, China
Updates

Check for updates
Copyright
© 2023 Shuaishuai, Tongtong, Dapeng, Mingran, Xukai, Yue, Hengliang, Guangzhi and Minglei.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wu Guangzhi, wuguangzhi@jlu.edu.cn; Zhang Minglei, zml669@jlu.edu.cn
† These authors have contributed equally to this work
This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.